For laboratory research use only - not for human consumption

Hub ยท Peptide Quality & Verification

How mass spectrometry confirms peptide identity

Mass spectrometry confirms peptide identity by weighing a peptide and comparing the result with the mass worked out from the named sequence. A peptide is a short chain of amino acids, the building blocks of proteins. A sequence is the order of those amino acids. Mass is molecular weight. A matching mass supports the sequence but does not prove it. So the European Medicines Agency (EMA) recommends at least two orthogonal tests (EMA/CHMP/CVMP/QWP/367182/2025). Orthogonal means built on different principles. The EMA is the European Union's medicines regulator.

Published 2026-10-04Updated 2026-10-04Written by Form Laboratories research team7 min read

Your body makes peptides every day. They are short chains of amino acids that carry messages between your cells. Even there, weight is a blunt clue, because two different amino acids can weigh exactly the same. A mass spectrometer is the instrument that does the weighing. It reads weight with great care. This page is part of the peptide quality & verification hub. It explains how a peptide is weighed, what a match means, and where a match stops.

Two questions run through it. How does an instrument weigh something far too small to see? And how do scientists tell apart molecules that weigh the same? Two neighbouring pages help. One is how to read a certificate of analysis, the maker's test sheet for one production run. The other is what a lot number lets a researcher verify, the code that names that run.

  • Guidethe peptide quality & verification hubHow research peptides are tested and verified: purity methods, certificates of analysis, batch traceability, and what each document can and cannot tell you.
  • Guidehow to read a certificate of analysisWhat a certificate of analysis shows: its fields, purpose and layout, how it differs from a safety data sheet, what purity and identity numbers prove, and where the paperwork stops.
  • Guidewhat a lot number lets a researcher verifyA batch or lot number identifies one production run. What that code lets a researcher check, what it ties together, and where its verifying power stops.

Key facts

Key facts for How mass spectrometry confirms peptide identity
MethodMass spectrometry (MS), often joined to liquid chromatography (LC-MS). Liquid chromatography sorts a dissolved mixture by how fast each part moves through a packed tube.
What it reportsThe mass-to-charge ratio (m/z). This is mass divided by the number of electric charges. It lets electric fields steer an ion, which is a charged molecule.
Unit of massThe dalton (Da). It is one twelfth of the mass of a carbon-12 atom. Carbon-12 is the most common form of carbon (International Bureau of Weights and Measures, The International System of Units, 9th edition, 2019)
Identity guidelineEMA/CHMP/CVMP/QWP/367182/2025, dated 4 December 2025. It recommends at least two orthogonal methods.
Earlier guidelineICH Q6A, dated 6 October 1999, from the International Council for Harmonisation (ICH). ICH writes shared drug-testing guidelines. Q6A says one retention time is not specific. A retention time is the delay before a part leaves the tube. Identity tests should tell closely related molecules apart. It says HPLC/MS is generally acceptable. That is high-performance liquid chromatography joined to a mass spectrometer.
Published worked exampleLeuprolide: calculated m/z 1209.6533, measured 1209.6515 (McCarthy et al., Pharmaceutical Research, 2023)
Does not show on its ownWhich catalogue lot a sample came from, purity, content, safety or permission. Purity is the share of the sample that is the named peptide. Content is how much peptide is present.
Science 1989International System of Units 2019Journal of Pharmaceutical Analysis 2015

What does mass spectrometry measure in a peptide?

Mass spectrometry measures the mass-to-charge ratio, written m/z, of ions made from a sample. An ion is a molecule carrying an electric charge. The m/z is its mass divided by its number of charges. Electrospray ionization turns dissolved molecules into ions. Each ion can carry several charges (Fenn et al., Science, 1989). Mass is counted in daltons (Da). Each dalton equals a twelfth of a carbon-12 atom's mass (International Bureau of Weights and Measures, 2019). The instrument records m/z values. Names and sequences come from interpreting them.

Atoms of one element come as isotopes. Isotopes differ in their neutrons, the particles in the atom's core. Most carbon atoms are carbon-12. A small share are the heavier carbon-13 (National Institute of Standards and Technology, Atomic Weights and Isotopic Compositions for Carbon). A peptide's monoisotopic mass is its mass built from the most common form of each element. Verbeke et al. report impurity masses this way (Verbeke et al., Journal of Pharmaceutical Analysis, 2015).

Pharmaceutical Research 2023Journal of Pharmaceutical Analysis 2015

How does a mass match confirm peptide identity?

A mass match confirms identity only as far as the measured mass equals the mass worked out from the named sequence. McCarthy et al. give a worked case. Leuprolide is a peptide of nine amino acids. Its calculated monoisotopic protonated m/z is 1209.6533, and the measured value was 1209.6515 (McCarthy et al., Pharmaceutical Research, 2023). Protonated means the molecule picked up one hydrogen ion, which supplies the charge. Agreement within 0.002 shows a fine reading of the weight. It supports the sequence but does not prove it, because other molecules can weigh the same.

A mass check can also catch the wrong product. Verbeke et al. examined 15 peptides chosen for varying purity. The main peak was the desired peptide for 14 of them (Verbeke et al., 2015). The main peak is the tallest signal on the chromatography chart. The fifteenth main peak sat 2.1 Da below the requested mass. That pointed to a disulfide bond, a sulfur-to-sulfur link between two cysteines (Verbeke et al., 2015). Cysteines are amino acids that carry sulfur. The 15 were not a random sample, so 14 of 15 is not a failure rate. The retatrutide molecular-formula record shows a formula and its calculated mass.

Proceedings of the National Academy of Sciences 1986Journal of Pharmaceutical Analysis 2015Pharmaceutical Research 2023EMA synthetic-peptide guideline 2025

How does fragmentation show a peptide's sequence?

Fragmentation shows sequence by breaking selected peptide ions into pieces and weighing the pieces. This two-stage method is called tandem mass spectrometry (MS/MS). Hunt et al. described reading amino acid sequences this way in 1986. They used collision-activated dissociation, where collisions knock the ions apart (Hunt et al., Proceedings of the National Academy of Sciences, 1986). Pieces that keep the start of the chain are called b ions. Pieces that keep its end are called y ions. Verbeke et al. saw a shift of 14 Da at b4 (first four amino acids) but not at b3 (first three). That placed a methyl group on the fourth amino acid of one impurity (Verbeke et al., 2015). A methyl group is a small carbon-and-hydrogen unit.

A published case shows what complete evidence looks like. For leuprolide, MS/MS gave complete coverage of the amino acid sequence. That means every position in the chain was accounted for (McCarthy et al., 2023). The EMA asks for representative spectra, fragment assignments and tables of calculated and observed masses (EMA/CHMP/CVMP/QWP/367182/2025). A bare statement that a mass matched is thinner evidence than that.

Pharmaceutical Research 2023EMA synthetic-peptide guideline 2025

Can two different peptides have the same mass?

Two different peptides can have the same mass. That is why a mass match cannot stand alone. McCarthy et al. note that isobaric amino acids may need extra techniques. Isobaric means identical mass. Their scheme uses amino acid analysis to tell leucine from isoleucine in bivalirudin, a peptide holding one of each (McCarthy et al., Pharmaceutical Research, 2023). Amino acid analysis counts which amino acids are present. The same paper lists chirality testing. This is a check for D-amino acids, the mirror-image forms of amino acids that some peptides contain.

The EMA lists molecular mass (MS or LC-MS) and amino acid sequence confirmation as separate tests. LC-MS/MS of the intact molecule is one technique for the second (EMA/CHMP/CVMP/QWP/367182/2025). Its list also gives enantiomeric purity, which is the share of the correct mirror-image form. That needs techniques that tell mirror images apart. A reading of mass alone fills only the first line.

EMA synthetic-peptide guideline 2025ICH Q6A 1999Pharmaceutical Research 2023

Which identity tests do guidelines expect for peptides?

Guidelines expect more than one kind of evidence for peptide identity. The EMA's December 2025 guideline covers synthetic peptides, which are built by chemistry rather than by living cells. It recommends at least two orthogonal methods. It names mass and LC-MS among the appropriate ones. It requires that the chosen tests unambiguously confirm the sequence (EMA/CHMP/CVMP/QWP/367182/2025). ICH Q6A (1999) states that identification by a single chromatographic retention time is not regarded as specific. It says HPLC/MS is generally acceptable. Two different principles give stronger evidence than one. A measured mass is only one principle.

The EMA text names other appropriate methods. Relative retention time compares a retention time with a reference. Peptide mapping cuts a peptide into pieces and weighs them. Bioactivity is a measured biological response. Amino acid analysis is another. So is NMR, nuclear magnetic resonance, which reads how atoms behave in a magnetic field (EMA/CHMP/CVMP/QWP/367182/2025). McCarthy et al. describe reference standards, which are materials that tests are compared against. They verify them by retention time, NMR, MS and chirality testing together (McCarthy et al., 2023).

Journal of Pharmaceutical Analysis 2015Pharmaceutical Research 2023ICH Q6A 1999

Evidence limits

What has research not shown about mass spectrometry and peptide identity?

Published evidence does not show that mass spectrometry alone proves peptide identity. None of the sources read for this page tested a catalogue lot. Verbeke et al. studied 98 synthetic quorum-sensing peptides, which are signalling molecules that bacteria use. They examined the main peak of only 15 (Verbeke et al., 2015). McCarthy et al. describe six reference standards, not commercial lots (McCarthy et al., 2023). ICH Q6A may apply to synthetic peptides of low molecular weight in marketing applications for new medicines (ICH Q6A, 1999).

This page explains methods. It does not test or certify any catalogue lot. A spectrum describes only the sample that was measured. The lot number on the label and the report is what ties the two together. A mass spectrum also says nothing about permission to supply or use a material. Research-use-only material is not a medicine and is not for human or animal use. For the paperwork around identity, see what research grade actually means.

  • Guidewhat research grade actually meansResearch grade is a catalogue phrase, not a published standard. What named grades like ACS and USP are, and what For Research Use Only does not mean.

Comparison

A reading checklist. It shows what a mass spectrometry result can show for each identity question, and which separate test answers what it leaves open. This is a general sketch, not a report from any real lot.

Comparison: How mass spectrometry confirms peptide identity
QuestionWhat mass spectrometry can showWhat needs a separate test
Does the measured mass equal the calculated mass?Whether the measured m/z agrees with the m/z calculated from the named sequenceWhether a different molecule of the same mass is the one measured
Is the order of amino acids right?Fragment ions placed along the chain, up to complete coverage of the sequenceA second, orthogonal identity method
Is it leucine or isoleucine?Nothing alone: the two amino acids weigh the sameAmino acid analysis
Is any amino acid the mirror-image D form?Nothing from mass alone: mirror-image forms weigh the sameChirality testing
Is the main chromatography peak the named peptide?LC-MS weighs what leaves the tube at each time, so a wrong main peak can be caughtA second method built on a different principle
How pure is it, and how much is there?Which masses are present, with impurities assigned by fragmentationChromatographic purity and content tests
Which catalogue lot does a spectrum describe?Nothing: a spectrum describes the sample that was measuredThe lot number matched between label and report

FAQ

What does MS/MS mean in peptide testing?

MS/MS means tandem mass spectrometry. The first stage weighs the intact ions. One ion type is selected and broken. The second stage weighs the pieces. Verbeke et al. called the two stages MS1 and MS2. They used the second to assign structures to 73% of 84 impurities (Verbeke et al., 2015).

Is a matching mass enough to show a peptide is what its name says?

A matching mass is necessary but not sufficient. The EMA recommends at least two orthogonal identity methods. It asks for tests that leave no doubt about the sequence (EMA, December 2025). Amino acids of identical mass are one reason. McCarthy et al. needed a separate test for leucine and isoleucine (McCarthy et al., 2023).

Does mass spectrometry measure peptide purity?

Mass spectrometry names what is present. The two studies cited here took purity from chromatography. Verbeke et al. measured purity from peak areas. They used mass spectrometry to identify the main peak and impurities. McCarthy et al. list purity and strength as chromatography tests. Strength is the amount of peptide (Verbeke et al., 2015; McCarthy et al., 2023).

Citations

4 sources
  1. Verbeke F et al. Journal of Pharmaceutical Analysis. 2015;5(3):169-181.
    doi:10.1016/j.jpha.2014.12.002

  2. McCarthy D et al. Pharmaceutical Research. 2023;40(6):1317-1328.
    doi:10.1007/s11095-023-03493-1

  3. Fenn JB et al. Science. 1989;246(4926):64-71.
    doi:10.1126/science.2675315

  4. Hunt DF et al. Proceedings of the National Academy of Sciences. 1986;83(17):6233-6237.
    doi:10.1073/pnas.83.17.6233

Written by

Form Laboratories research team

Perth, Western Australia. We supply research-use-only reference material.

Written in-house
These articles are written and maintained by our own research team, not by a named clinician.
Built from the record
Every figure comes from published literature, listed in full above with a link to the original paper.
No use directions
We describe what the research measured. We give no use directions, preparation steps or advice.

Form Laboratories supplies research-use-only reference material. This article is an educational summary of published third-party literature. It is not medical advice, not a use instruction, and research material is not for human or animal use.

2026 Form Laboratories - Research use only - Perth WAPerth WA 6000 - dispatched Australia-wide via Australia Post or CouriersPlease